These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7905101)

  • 1. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women.
    Sack MN; Rader DJ; Cannon RO
    Lancet; 1994 Jan; 343(8892):269-70. PubMed ID: 7905101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women.
    Wen Y; Doyle MC; Norris LA; Sinnott MM; Cooke T; Harrison RF; Feely J
    Br J Clin Pharmacol; 1999 Mar; 47(3):315-21. PubMed ID: 10218915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the antioxidant effect of estriol and estradiol on low density lipoproteins in post-menopausal women].
    Arteaga E; Villaseca P; Rojas A; Arteaga A; Bianchi M
    Rev Med Chil; 1998 May; 126(5):481-7. PubMed ID: 9731428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
    Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
    Menopause; 2001; 8(6):408-19. PubMed ID: 11723413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins.
    Berg GA; Siseles N; González AI; Ortiz OC; Tempone A; Wikinski RW
    Menopause; 2001; 8(1):51-7. PubMed ID: 11201516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of long-term hormone replacement therapy on in vivo and in vitro markers of lipid oxidation.
    Rontu R; Solakivi T; Teisala K; Lehtimäki T; Punnonen R; Jokela H
    Free Radic Res; 2004 Feb; 38(2):129-37. PubMed ID: 15104206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the antioxidative effects of 17 beta-estradiol modified by concomitant administration of a progestin?
    Schröder J; Dören M; Schneider B; Oettel M
    Maturitas; 1996 Oct; 25(2):133-9. PubMed ID: 8905604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women.
    Nenseter MS; Volden V; Berg T; Drevon CA; Ose L; Tonstad S
    Eur J Clin Invest; 1996 Dec; 26(12):1062-8. PubMed ID: 9013080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in lipid metabolism in postmenopausal Japanese women using hormone therapy evaluated by capillary isotachophoresis: a pilot study.
    Inoue Y; Zhang B; Sadamori R; Shirota K; Saku K; Kawarabayashi T
    Menopause; 2008; 15(1):157-63. PubMed ID: 17603392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women.
    Wakatsuki A; Ikenoue N; Okatani Y; Fukaya T
    J Am Coll Cardiol; 2001 Feb; 37(2):425-30. PubMed ID: 11216957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lower dose of oral conjugated equine estrogen on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Circulation; 2003 Aug; 108(7):808-13. PubMed ID: 12900341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
    N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of soygerm extracts on blood lipoproteins, antioxidative capacity and urinary estrogen metabolites in postmenopausal women on hormone therapy.
    Hsu IP; Jou HJ; Huang CW; Wang TA; Wu WH
    Int J Gynaecol Obstet; 2007 Jul; 98(1):29-33. PubMed ID: 17467711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
    Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.